HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
335.98
+11.36 (3.50%)
Apr 23, 2025, 4:00 PM EDT - Market closed
HCA Healthcare Analyst Ratings
Total Analysts
17
Consensus Rating
Buy
Price Target
$376.20
Upside
+11.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy → Hold Downgrades $396 → $336 | Buy → Hold | Downgrades | $396 → $336 | +0.01% | Apr 15, 2025 |
| Guggenheim | Guggenheim | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Apr 9, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $405 → $384 | Buy | Maintains | $405 → $384 | +14.29% | Jan 27, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $380 → $370 | Strong Buy | Maintains | $380 → $370 | +10.13% | Jan 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $405 | Buy | Reiterates | $405 | +20.54% | Jan 27, 2025 |
| Barclays | Barclays | Buy Maintains $392 → $366 | Buy | Maintains | $392 → $366 | +8.94% | Jan 27, 2025 |
| Keybanc | Keybanc | Buy Maintains $420 → $370 | Buy | Maintains | $420 → $370 | +10.13% | Jan 7, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $430 → $390 | Strong Buy | Maintains | $430 → $390 | +16.08% | Jan 6, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $406 → $355 | Hold | Maintains | $406 → $355 | +5.66% | Dec 17, 2024 |
| JP Morgan | JP Morgan | Hold Initiates $380 | Hold | Initiates | $380 | +13.10% | Dec 17, 2024 |
| Wells Fargo | Wells Fargo | Hold → Sell Downgrades $400 → $320 | Hold → Sell | Downgrades | $400 → $320 | -4.76% | Nov 25, 2024 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 22, 2024 |
| Barclays | Barclays | Buy Maintains $396 → $392 | Buy | Maintains | $396 → $392 | +16.67% | Nov 8, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $395 → $400 | Hold | Maintains | $395 → $400 | +19.05% | Nov 6, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $450 → $440 | Strong Buy | Maintains | $450 → $440 | +30.96% | Oct 28, 2024 |
| Keybanc | Keybanc | Buy Maintains $475 → $420 | Buy | Maintains | $475 → $420 | +25.01% | Oct 28, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.